EpiTherapeutics' Series A - II Round

EpiTherapeutics raised a round of funding on April 08, 2014.

EpiTherapeutics is developing novel innovative cancer drugs based on the world leading research in epigenetics conducted by Professor Kristian Helin and his group at Biotech Research & Innovation Cent…

Articles about EpiTherapeutics' Series A - II Round: